News
CURESEARCH for Children's Cancer Announces Inaugural Catapult Award Recipient
CureSearch is proud to announce its inaugural Catapult Award has been granted to Dr. Ranjit Bindra of the Yale Cancer Center, supporting his ground-breaking work on a novel drug for pediatric glioma. CureSearch’s Catapult Awards support high impact, clinic ready projects as part of an overall research strategy focused on moving treatments into development in an accelerated timeframe. Bindra has an established history with CureSearch as a highly productive Young Investigator Award recipient from 2015-2017.
“Childhood cancer continues to be the number one disease killer of children. Through the Catapult Awards, we are directly funding Phase I or Phase II clinical research that will drive new treatments to the marketplace for the kids who need it most,” said Kay Koehler, CureSearch CEO. “With the Catapult Awards, we are funding only the most promising therapies – those that show a strong potential for future approval and commercialization, quickly.”
Source: CURESEARCH